COVID-19 presents numerous ongoing challenges. Research continues into vaccines and antivirals, as well as the known and unknown effects of long covid on individual health and society more broadly. There have also been challenges with access and reimbursement in low and middle-income countries.
- Past Event
- OHE Webinar
- January 2023
Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic
- July 2021
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
- April 2021
Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic
- September 2020
Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?
- August 2020
Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?
- June 2020
The 2020 OHE Annual Lecture Explores the Question: How Should the World Pay for a COVID-19 Vaccine?
- May 2020